Chromatin engineering offers an opportunity to advance epigenetic cancer therapy
- PMID: 31582843
- DOI: 10.1038/s41594-019-0299-6
Chromatin engineering offers an opportunity to advance epigenetic cancer therapy
References
-
- Lungu, C., Pinter, S., Broche, J., Rathert, P. & Jeltsch, A. Nat. Commun. 8, 649 (2017). - DOI
-
- Tekel, S. J., Barrett, C., Vargas, D. & Haynes, K. A. Biochemistry 57, 4707–4716 (2018). - DOI
-
- Delachat, A. M.-F. et al. Cell Chem. Biol. 25, 51–56.e6 (2018). - DOI
-
- Sanchez, O. F., Mendonca, A., Carneiro, A. D. & Yuan, C. ACS Sens. 2, 426–435 (2017). - DOI
-
- Bracken, A. P. & Helin, K. Nat. Rev. Cancer 9, 773–784 (2009). - DOI
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
